Cite

HARVARD Citation

    Martín‐Rojas, R. et al. (2022). Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel. Clinical case reports. 10 (1), p. n/a. [Online]. 
  
Back to record